Osteopontin, a Protein with Cytokine‐like Properties, is Associated with Inflammation in Crohn's Disease
- 16 April 2007
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 65 (5) , 453-460
Abstract
In Crohn's disease (CD) mucosal T‐cells produce increased interferon‐γ (IFN‐γ) and tumour necrosis factor‐α (TNF‐α) levels and TNF‐α antibody treatment [Infliximab (Ifx)] is effective. Osteopontin (OPN), a glycoprotein stimulating activated T‐lymphocytes, may be involved in the disturbed immune‐regulation but also in normal immune‐homeostasis and mucosal repair, since it is expressed in many tissues and present in human milk. This study investigates plasma‐OPN levels in CD patients during Ifx treatment and the in vitro effect of OPN on intestinal T cells. Thirty‐seven CD patients received three Ifx doses at week 0, 2 and 6. Blood samples, colonic biopsies and clinical scores were obtained before treatment and at week 8, 26 and 52. In‐vivo activated T‐cell cultures were established from colonic biopsies in the presence of interleukin (IL)‐2 and IL‐4. The in vitro effect of OPN stimulation on T‐cell IFN‐γ, TNF‐α, and IL‐10 production was measured. Plasma‐OPN was increased in active CD (increased CRP‐level) compared with quiescent disease (P = 0.02) and declined after three Ifx doses (P = 0.04). It was inversely correlated with in vitro T‐cell IL‐10 production. OPN increased CD69 and CD25 expression and enhanced T‐cell IFN‐γ and TNF‐α production in a dose‐dependent fashion with higher levels in CD than in healthy controls (HC), but induced a concomitant higher IL‐10 production in HC than CD. In conclusion, plasma‐OPN levels are related to CD inflammation. In vitro, OPN‐stimulated IL‐10 production increases less in T‐cell cultures from CD patients than from HC, indicating that IL‐10 deficiency may be involved in the defect immune‐regulation in CD, even after OPN stimulation.Keywords
This publication has 24 references indexed in Scilit:
- Exacerbated tissue destruction in DSS‐induced acute colitis of OPN‐null mice is associated with downregulation of TNF‐α expression and non‐programmed cell deathJournal of Cellular Physiology, 2006
- Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn’s disease and diverticulitisJournal of Gastroenterology, 2005
- In situ Activated Intestinal T Cells Expanded in vitro – without Addition of Antigen – Produce IFN-γ and IL-10 and Preserve Their Function during GrowthExperimental and Clinical Immunogenetics, 2001
- Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammationInternational Journal of Experimental Pathology, 2000
- Osteopontin Expression Correlates with Clinical Outcome in Patients with Mycobacterial InfectionThe American Journal of Pathology, 2000
- Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) ImmunityScience, 2000
- Ultrastructural Immunogold Localization of Osteopontin in Human Gastric MucosaJournal of Histochemistry & Cytochemistry, 1997
- Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)Clinical and Experimental Immunology, 1995
- Posttranslational modifications of bovine osteopontin: Identification of twenty‐eight phosphorylation and three O‐glycosylation sitesProtein Science, 1995
- Purification and characterization of three proteins isolated from the proteose peptone fraction of bovine milkJournal of Dairy Research, 1993